Page 4 - Strides Pharma News Today

The product is bioequivalent and therapeutically equivalent to the reference listed drug Vascepa of Amarin. It will be manufactured at the companys facility in Bengaluru, it added. The Icosapent Ethyl capsules have a market size of around USD 1.3 billion, Strides said, citing IQVIA.

ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.

Sharekhan recommended Hold rating on Strides Pharma Science with a target price of Rs 600 in its research report dated September 26, 2023.

Stocks that were in focus included names like Strides Pharma, which fell 1.84%, Tata Steel, which rose 1.22%, and Sun TV, whose shares declined 1.28% on Tuesday.

India Business News: Pharmaceutical company Strides Pharma has received board approval for a scheme of arrangement to create a separate contract development and manufactur

Indian shares are set to open lower on Tuesday, with higher-for-longer global interest rate expectations driving continuous foreign outflows from the domestic market amid subdued global sentiment. ...

Ashish Kacholia has sold stake in Delta Corp Ltd through bulk deals on Monday. The ace investor has offloaded about 15 lakh shares 0.56% in the company at Rs 144.65 apiece, according to exchange data.

Top stocks to watch: Strides Pharma Science, HDFC Asset Management Company, CSB Bank, UTI Asset Management Company, Shradha Industries, CEAT, Tata Steel and some others will be in focus on Tuesday (September 26).

As per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. The consensus recommendation from 3 analysts for the stock is a Buy.

Moodys upgrades Tata Steels rating to Baa3, citing solid market position in India and deleveraging efforts.